首页> 外文期刊>Journal of diabetes research. >Evaluation of Hypoglycemic Efficacy of Tangningtongluo Formula, a Traditional Chinese Miao Medicine, in Two Rodent Animal Models
【24h】

Evaluation of Hypoglycemic Efficacy of Tangningtongluo Formula, a Traditional Chinese Miao Medicine, in Two Rodent Animal Models

机译:两种啮齿动物术语中唐宁络罗络公式的降血糖疗效评价

获取原文
获取原文并翻译 | 示例
       

摘要

Traditional Chinese medicines largely lack adequate and scientifically rigorous evidence regarding efficacy and functional mechanisms. The present study was aimed to confirm the hypoglycemic effect of Tangningtongluo (TNTL) formula, a traditional Chinese Miao medicine, in two animal models: high-fat diet and streptozotocin- (STZ-)induced diabetic rats and C57BL/KsJ-db/db diabetic mice. After 4 weeks, TNTL intervention in STZ- induced diabetic rats yielded in significant improvement on the glucose tolerance test. Moreover, the islet histopathology showed that oral TNTL reduced the severity of islet necrosis in pancreases tissue. Compared with diabetic controls, a 12-week TNTL treatment regimen (dosages = 0.9, 1.8, and 3.6 g/kg) in db/db mice significantly decreased fasting glucose and HbA1c. Additionally, oral glucose tolerance in TNTL-treated mice improved significantly, compared with diabetic mice receiving metformin. Finally, tissue histopathology and biochemical index evaluations revealed significant improvement in TNTL-treated mice. Taken together, our results show that TNTL exerted a strong hypoglycemic effect in two diabetic rodent animal models, preserving beta-cells in the pancreas islet and reducing the risk of diabetic retinopathy and nephropathy.
机译:中药在很大程度上缺乏有关疗效和功能机制的充足和科学严格的证据。本研究旨在确认唐宁络综合(TNTL)公式,中产病,两种动物模型的降血糖作用:高脂饮食和链脲佐菌素 - (STZ-)诱发糖尿病大鼠和C57BL / KSJ-DB / DB糖尿病小鼠。 4周后,STZ诱导的糖尿病大鼠的TNTL干预在葡萄糖耐量试验中产生显着改善。此外,胰岛组织病理学表明口服TNTL降低了胰腺释放组织中的胰岛坏死的严重程度。与糖尿病对照相比,DB / DB小鼠中的12周TNTL治疗方案(剂量= 0.9,1.8和3.6g / kg)显着降低了空腹葡萄糖和HBA1c。另外,与接受二甲双胍的糖尿病小鼠相比,TNT1处理的小鼠中的口服葡萄糖耐量显着改善。最后,组织组织病理学和生物化学指标评估显示出TNT1处理的小鼠的显着改善。我们的结果表明,TNTL在两个糖尿病啮齿动物模型中施加了强烈的降血糖作用,在胰腺胰岛素中保留了β细胞,并降低了糖尿病视网膜病变和肾病的风险。

著录项

  • 来源
    《Journal of diabetes research.》 |2014年第2期|共12页
  • 作者单位

    Chinese Acad Med Sci Inst Med Plant Dev Key Lab Bioact Subst &

    Resources Utilizat Chinese;

    Chinese Acad Med Sci Inst Med Plant Dev Key Lab Bioact Subst &

    Resources Utilizat Chinese;

    Heilongjiang Univ Chinese Med Harbin 150040 Heilongjiang Peoples R China;

    Harbin Univ Commerce Pharmaceut Coll Harbin 150076 Heilongjiang Peoples R China;

    China Acad Tradit Chinese Med Xiyuan Hosp Beijing 100091 Peoples R China;

    Chinese Acad Med Sci Inst Med Plant Dev Key Lab Bioact Subst &

    Resources Utilizat Chinese;

    Chinese Acad Med Sci Inst Med Plant Dev Key Lab Bioact Subst &

    Resources Utilizat Chinese;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 内分泌腺疾病及代谢病;
  • 关键词

  • 入库时间 2022-08-20 09:06:33

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号